Mesoblast (MEOBF) Shares Outstanding (Weighted Average) (2017 - 2025)

Mesoblast (MEOBF) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $1.5 billion as the latest value for Q2 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 15.11% to $1.5 billion in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Jun 2025, up 15.11% year-over-year, with the annual reading at $1.5 billion for FY2025, 15.11% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $1.5 billion in Q2 2025 for Mesoblast, up from $1.3 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.5 billion in Q2 2025 to a low of $682.9 million in Q2 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $1.1 billion across 5 years, with a median of $1.2 billion in 2021.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 41.29% in 2022 and later skyrocketed 61.1% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $1.2 billion in 2021, then crashed by 41.29% to $682.9 million in 2022, then grew by 19.15% to $813.7 million in 2023, then skyrocketed by 61.1% to $1.3 billion in 2024, then increased by 15.11% to $1.5 billion in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for MEOBF at $1.5 billion in Q2 2025, $1.3 billion in Q2 2024, and $813.7 million in Q2 2023.